Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 13.5 | 64 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 12.0 | 45 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 18.5 | 36 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 24.5 | 34 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 15.0 | 26 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 24.5 | 40 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 13.0 | 37 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 10.5 | 28 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | G-CSF | 16.0 | 42 | |
0 | G-CSF | 11.0 | 53 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 19.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 21.0 | 89 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 14.0 | 50 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 20.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 17.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 12.0 | 82 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 36.0 | 77 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 23.0 | 52 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 33.0 | 79 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 32.0 | 61 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 13.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 18.5 | 72 | |
RA2159 | 3 | G-CSF | 9.5 | 72 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | G-CSF | 8.5 | 50 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | G-CSF | 12.5 | 66 |